Κυριακή 24 Φεβρουαρίου 2019

A critical review of the chest CT scans performed to detect asymptomatic synchronous metastasis in new and recurrent breast cancers

Chest computed tomography (CTC) has now replaced chest X-ray (CXR) as the first choice of investigation to stage breast cancers in most centers in Australia. Routine staging is not recommended in early breast ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2H2pvxN

Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1–2 and cN0 breast cancer

The prognostic value of sentinel lymph node (SLN) metastases may be minimized by the limited disease burden of lymph node metastases and tailoring adjuvant therapy based on breast cancer biology. The aim of th...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2tBPG6v

A critical review of the chest CT scans performed to detect asymptomatic synchronous metastasis in new and recurrent breast cancers

Chest computed tomography (CTC) has now replaced chest X-ray (CXR) as the first choice of investigation to stage breast cancers in most centers in Australia. Routine staging is not recommended in early breast ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2H2pvxN

Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1–2 and cN0 breast cancer

The prognostic value of sentinel lymph node (SLN) metastases may be minimized by the limited disease burden of lymph node metastases and tailoring adjuvant therapy based on breast cancer biology. The aim of th...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2tBPG6v

Editorial Board

Publication date: April 2019

Source: Auris Nasus Larynx, Volume 46, Issue 2

Author(s):



from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2VbNhuY

Editorial Board

Publication date: April 2019

Source: Auris Nasus Larynx, Volume 46, Issue 2

Author(s):



from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2VbNhuY

Immunotherapy for egg allergy may allow patients to eat egg safely long after treatment

(University of North Carolina Health Care) After completing up to four years of egg oral immunotherapy (eOIT) treatment, certain participants were able to safely incorporate egg into their diet for five years. This new research was presented by the study's first author, Edwin Kim, MD, at the annual American Academy of Allergy, Asthma and Immunology (AAAAI) conference in San Francisco. (Source: EurekAlert! - Medicine and Health)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2GIlBuK

Exclusive breastfeeding lowers odds of some schoolchildren having eczema

(Children's National Health System) Children exclusively breastfed for the first three months of life had significantly lower odds of having eczema at age 6 compared with peers who were not breastfed or were breastfed for less time, according to preliminary research presented during the American Academy of Allergy, Asthma& Immunology 2019 Annual Meeting. (Source: EurekAlert! - Social and Behavioral Science)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Nq7CKy

Immunotherapy for egg allergy may allow patients to eat egg safely long after treatment

(University of North Carolina Health Care) After completing up to four years of egg oral immunotherapy (eOIT) treatment, certain participants were able to safely incorporate egg into their diet for five years. This new research was presented by the study's first author, Edwin Kim, MD, at the annual American Academy of Allergy, Asthma and Immunology (AAAAI) conference in San Francisco. (Source: EurekAlert! - Medicine and Health)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2GIlBuK

Exclusive breastfeeding lowers odds of some schoolchildren having eczema

(Children's National Health System) Children exclusively breastfed for the first three months of life had significantly lower odds of having eczema at age 6 compared with peers who were not breastfed or were breastfed for less time, according to preliminary research presented during the American Academy of Allergy, Asthma& Immunology 2019 Annual Meeting. (Source: EurekAlert! - Social and Behavioral Science)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Nq7CKy

Immunotherapy for egg allergy may allow patients to eat egg safely long after treatment

(University of North Carolina Health Care) After completing up to four years of egg oral immunotherapy (eOIT) treatment, certain participants were able to safely incorporate egg into their diet for five years. This new research was presented by the study's first author, Edwin Kim, MD, at the annual American Academy of Allergy, Asthma and Immunology (AAAAI) conference in San Francisco. (Source: EurekAlert! - Medicine and Health)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2GIlBuK

Exclusive breastfeeding lowers odds of some schoolchildren having eczema

(Children's National Health System) Children exclusively breastfed for the first three months of life had significantly lower odds of having eczema at age 6 compared with peers who were not breastfed or were breastfed for less time, according to preliminary research presented during the American Academy of Allergy, Asthma& Immunology 2019 Annual Meeting. (Source: EurekAlert! - Social and Behavioral Science)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Nq7CKy

Immunotherapy for egg allergy may allow patients to eat egg safely long after treatment

(University of North Carolina Health Care) After completing up to four years of egg oral immunotherapy (eOIT) treatment, certain participants were able to safely incorporate egg into their diet for five years. This new research was presented by the study's first author, Edwin Kim, MD, at the annual American Academy of Allergy, Asthma and Immunology (AAAAI) conference in San Francisco. (Source: EurekAlert! - Medicine and Health)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2GIlBuK

Exclusive breastfeeding lowers odds of some schoolchildren having eczema

(Children's National Health System) Children exclusively breastfed for the first three months of life had significantly lower odds of having eczema at age 6 compared with peers who were not breastfed or were breastfed for less time, according to preliminary research presented during the American Academy of Allergy, Asthma& Immunology 2019 Annual Meeting. (Source: EurekAlert! - Social and Behavioral Science)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Nq7CKy

Impact of Anesthesia on Long-term Outcomes in Patients With Supratentorial High-grade Glioma Undergoing Tumor Resection: A Retrospective Cohort Study

Background: Intravenous and inhalational anesthesia might have different associations with long-term outcome in cancer patients, with reports of adverse effects of inhalation anesthesia. However, the effects of anesthesia in patients with high-grade glioma (HGG) are not known. Methods: This study investigated 154 patients who received propofol and 140 patients who received sevoflurane for maintenance of anesthesia during HGG tumor resection. The primary outcomes were progression-free survival and overall survival. Results: Median progression-free survival was 10 months (interquartile range [IQR], 6 to 18) versus 11 months (IQR 6 to 20; P=0.674), and median overall survival was 18 months (IQR, 11 to 39) versus 18 months (IQR, 10 to 44; P=0.759) in patients maintained with propofol and sevoflurane, respectively. Higher preoperative Karnofsky performance status and postoperative chemotherapy were associated with a reduced hazard of tumor progression or death, whereas higher age-adjusted Charlson comorbidity index and longer duration of anesthesia were associated with an increased hazard of progression or death. World Health Organization tumor classification IV and incomplete tumor resection were associated with an increased hazard of tumor progression but not death. Anesthesia maintenance with sevoflurane increased the risk of death in patients with Karnofsky performance status

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2ViRpcV

Difficult Central Venous Cannulation: An Overlooked Intracranial Cause

No abstract available

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Es9pvS

Impact of Anesthesia on Long-term Outcomes in Patients With Supratentorial High-grade Glioma Undergoing Tumor Resection: A Retrospective Cohort Study

Background: Intravenous and inhalational anesthesia might have different associations with long-term outcome in cancer patients, with reports of adverse effects of inhalation anesthesia. However, the effects of anesthesia in patients with high-grade glioma (HGG) are not known. Methods: This study investigated 154 patients who received propofol and 140 patients who received sevoflurane for maintenance of anesthesia during HGG tumor resection. The primary outcomes were progression-free survival and overall survival. Results: Median progression-free survival was 10 months (interquartile range [IQR], 6 to 18) versus 11 months (IQR 6 to 20; P=0.674), and median overall survival was 18 months (IQR, 11 to 39) versus 18 months (IQR, 10 to 44; P=0.759) in patients maintained with propofol and sevoflurane, respectively. Higher preoperative Karnofsky performance status and postoperative chemotherapy were associated with a reduced hazard of tumor progression or death, whereas higher age-adjusted Charlson comorbidity index and longer duration of anesthesia were associated with an increased hazard of progression or death. World Health Organization tumor classification IV and incomplete tumor resection were associated with an increased hazard of tumor progression but not death. Anesthesia maintenance with sevoflurane increased the risk of death in patients with Karnofsky performance status

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2ViRpcV

Difficult Central Venous Cannulation: An Overlooked Intracranial Cause

No abstract available

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Es9pvS

Σάββατο 23 Φεβρουαρίου 2019

Preparation of truncated tissue factor antineuropilin-1 monoclonal antibody conjugate and identification of its selective thrombosis in tumor blood vessels

In recent decades, selectively inducing tumor vascular thrombosis, followed by necrosis of tumor tissues has been a promising and potential anticancer strategy. In this report, we prepared a kind of vascular targeting drug that consists of anti-neuropilin-1 monoclonal antibody (anti-NRP-1 mAb) and truncated tissue factor (tTF). Anti-NRP-1 mAb could guide tTF to the surface of tumor vascular endothelial cells and lead to subsequent vascular embolization. This vascular targeting drug, which is also one of the antibody drug conjugates, was generated using a coupling method with water-soluble 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and N-hydroxysulfosuccimide. Afterwards, in-vitro and in-vivo assays were performed to characterize its potential coagulation ability and antitumor activity. In-vitro experiments indicated that tTF-anti-NRP-1 monoclonal antibody (tTF–mAb) retained both the targeting activity of anti-NRP-1 mAb and the procoagulant activity of tTF. Live imaging system was used to assess its biodistribution and tumor-binding capability, which also yielded promising results. Furthermore, in-vivo studies showed that tTF–mAb was capable of significantly inducing tumor vascular thrombosis and inhibiting tumor growth in nude mice bearing subcutaneous xenografts, and histopathologic changes were rarely observed in normal organs. Correspondence to Ting Wu, PhD, Cancer Research Center, Medical College, Xiamen University, Xiangan South Road, Xiamen, Fujian 361102, China Tel:+86 592 218 0587; fax: +86 592 218 6731; e-mail: wuting78@aliyun.com Received October 23, 2018 Accepted January 26, 2019 Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Ntw5Pe

PSMA5 promotes the tumorigenic process of prostate cancer and is related to bortezomib resistance

Proteasome α5 subunit (PSMA5) is related to poor prognosis in various cancers. The first therapeutic proteasome inhibitor, bortezomib, induces apoptosis, suppressing cell growth in many tumor types. However, the effects of PSMA5 and bortezomib in prostate cancer (PCa) are still unknown. In this study, we investigated whether PSMA5 is associated with the tumorigenic progression and the interaction of PSMA5 with bortezomib in PCa. We knocked down PSMA5 with siRNA and studied the changes in cell viability and motility with Cell Counting Kit-8, quantitative PCR, fluorescence-activated cell sorting, scratch, and invasion assays. We also investigated the effect of PSMA5 in PCa cells treated with bortezomib and in those that are resistant to bortezomib. We found that silencing PSMA5 inhibited cell proliferation, induced apoptosis, restricted cell migration and invasion, and demonstrated a coordinated effect with bortezomib. Cells resistant to bortezomib gained sensitivity to bortezomib after PSMA5 was knocked down. Our results show, for the first time, that PSMA5 promotes the tumorigenic process of PCa and is linked to bortezomib resistance. * Zhenrui Fu and Chao Lu contributed equally to the writing of this article. Correspondence to Baomin Qiao, PhD, Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Pingjiang Road 23, Hexi District, 300211 Tianjin, China Tel: +86 228 832 9692; fax: +86 228 832 8695; e-mail: qiaobaomin2@126.com Received August 24, 2018 Accepted February 5, 2019 Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2GIlXkP